Adaptive Announces IVDR Certification for clonoSEQ® in European Union
29. August 2024 07:30 ET
|
Adaptive Biotechnologies
SEATTLE, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...